Editorial
doi: 10.1046/j.1365-2249.2002.01967.x.
High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders
- PMID: 12197877
- PMCID: PMC1906471
- DOI: 10.1046/j.1365-2249.2002.01967.x
Item in Clipboard
Editorial
High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders
Clin Exp Immunol.
2002 Sep.
No abstract available
Comment on
-
Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.Clin Exp Immunol. 2002 Sep;129(3):533-40. doi: 10.1046/j.1365-2249.2002.01942.x. Clin Exp Immunol. 2002. PMID: 12197896 Free PMC article. Clinical Trial.
Similar articles
-
High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.J Am Acad Dermatol. 2007 Jun;56(6):960-7. doi: 10.1016/j.jaad.2006.06.029. Epub 2007 Mar 21. J Am Acad Dermatol. 2007. PMID: 17368865
-
Dermatological uses of high-dose intravenous immunoglobulin.Arch Dermatol. 1998 Jan;134(1):80-6. doi: 10.1001/archderm.134.1.80. Arch Dermatol. 1998. PMID: 9449914 Review.
-
Treatment Update of Autoimmune Blistering Diseases.Dermatol Clin. 2019 Apr;37(2):215-228. doi: 10.1016/j.det.2018.12.003. Epub 2019 Feb 14. Dermatol Clin. 2019. PMID: 30850044 Review.
-
Autoimmune bullous diseases: diagnosis and management.Dermatol Nurs. 2006 Feb;18(1):20-5. Dermatol Nurs. 2006. PMID: 16550892 Review.
-
A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.Clin Exp Dermatol. 2001 Mar;26(2):127-31. doi: 10.1046/j.1365-2230.2001.00779.x. Clin Exp Dermatol. 2001. PMID: 11298100 Review.
Cited by
-
High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.Clin Rev Allergy Immunol. 2010 Apr;38(2-3):186-95. doi: 10.1007/s12016-009-8153-y. Clin Rev Allergy Immunol. 2010. PMID: 19557317 Review.
-
Intravenous Immunoglobulin: Revisited - My Experience.Indian J Dermatol. 2021 May-Jun;66(3):329. doi: 10.4103/ijd.IJD_559_17. Indian J Dermatol. 2021. PMID: 34446966 Free PMC article.
-
Biologics in dermatology: an integrated review.Indian J Dermatol. 2014 Sep;59(5):425-41. doi: 10.4103/0019-5154.139859. Indian J Dermatol. 2014. PMID: 25284845 Free PMC article. Review.
-
The role of intravenous immunoglobulin preparations in the treatment of systemic sclerosis.Int J Rheumatol. 2011;2011:829751. doi: 10.1155/2011/829751. Epub 2011 Nov 2. Int J Rheumatol. 2011. PMID: 22121376 Free PMC article.
-
Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.J Clin Immunol. 2007 May;27(3):233-45. doi: 10.1007/s10875-007-9088-9. Epub 2007 Mar 11. J Clin Immunol. 2007. PMID: 17351760 Review.
References
-
- Jolles S, Hughes J, Whittaker S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol. 1998;134:80–6. - PubMed
-
- Hall R, Murray J. Autoimmune skin disease. In: Rich R, editor. Clinical immunology principles and practice. Vol. 2. St. Louis, MO: Mosby; 1996. pp. 1316–42.
-
- Tappeiner G, Steiner A. High-dosage intravenous gamma globulin. therapeutic failure in pemphigus and pemphigoid. J Am Acad Dermatol. 1989;20:684–5. - PubMed
-
- Humbert P, Derancourt C, Aubin F, Agache P. Effects of intravenous gamma-globulin in pemphigus. J Am Acad Dermatol. 1990;22:326. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
